Immune signatures as predictors for immunotherapy regimens in metastatic RCC
Published in Onkologi SE, 2024
Discussion on host immune signatures as predictive biomarkers for immunotherapy response in metastatic RCC.
Marc Machaalani, MD
Postdoctoral Research Fellow
- Boston, MA
- Dana-Farber Cancer Institute
- Google Scholar
- ORCID
- PubMed
- ResearchGate
- X (formerly Twitter)